Pieris Pharmaceuticals Appoints Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical Development Pharmaceutical Investing
3D Signatures Announces Close of Private Placement With Strategic Partner and Prospectus Update Life Science Investing
Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™ Pharmaceutical Investing
Vitality Biopharma Achieves Cannabinoid Pharmaceutical Biosynthesis Breakthrough Pharmaceutical Investing
DelMar Pharmaceuticals Presents Poster at AACR's Ovarian Cancer Special Conference on the Mechanistic Rationale for VAL-083 Overcoming Treatment Resistance in Ovarian Cancer Pharmaceutical Investing
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343 Pharmaceutical Investing
